Detected ·
Sightera Biosciences
€3M—
Sightera Biosciences, a Belgian techbio spin-off from the University of Antwerp, raised €3M in pre-seed funding led by Entourage Ventures, Anacura, and Qbic Fund. The company trains AI models on patient-derived drug-response data to engineer small molecules targeting real human disease biology, with a lead oncology program targeting KRAS-mutant cancers.
- Website
- www.sightera-biosciences.com
- Amount
- €3 000 000 EUR
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-18 12:03:52 UTC
- Signal ID
- 437f99da-63cb-4362-ac1e-c67cd0b2830a
As the API returns it
{
"id": "437f99da-63cb-4362-ac1e-c67cd0b2830a",
"created_at": "2026-07-18T12:03:52.413373Z",
"company_name": "Sightera Biosciences",
"company_website_url": "www.sightera-biosciences.com",
"company_linkedin_url": "https://www.linkedin.com/company/sightera-biosciences",
"event_type": "funding",
"funding_amount": 3000000,
"funding_currency": "EUR",
"funding_stage": null,
"message": "*Sightera Biosciences, a Belgian techbio spin-off from the University of Antwerp, raised €3M in pre-seed funding led by Entourage Ventures, Anacura, and Qbic Fund. The company trains AI models on patient-derived drug-response data to engineer small molecules targeting real human disease biology, with a lead oncology program targeting KRAS-mutant cancers.*"
}